Dr. Reddys Laboratories is currently trading at Rs. 2755.90, down by 26.95 points or 0.97% from its previous closing of Rs. 2782.85 on the BSE.
The scrip opened at Rs. 2783.00 and has touched a high and low of Rs. 2829.00 and Rs. 2736.15 respectively. So far 56470 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2965.20 on 02-May-2019 and a 52 week low of Rs. 2065.30 on 15-Feb-2019.
Last one week high and low of the scrip stood at Rs. 2829.00 and Rs. 2736.15 respectively. The current market cap of the company is Rs. 45651.87 crore.
The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 45.04% and 14.03% respectively.
Dr. Reddy's Laboratories has reported around four-fold jump in its net profit at Rs 1,365.10 crore for the quarter ended September 30, 2019 as compared to Rs 346.20 crore for the same quarter in the previous year. Total income of the company increased by 30.19% at Rs 3,522.70 crore for Q2FY20 as compared Rs 2,705.80 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported over two-fold jump in its net profit at Rs 1,106.80 crore for the quarter under review as compared to Rs 518.30 crore for the same quarter in the previous year. Total income of the company increased by 23.34% at Rs 4,866.80 crore for Q2FY20 as compared Rs 3,945.70 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |